The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Person who experienced the adverse event (patient)

Event ID CASEID CASEVERSION I F COD EVENT DT MFR DT INIT FDA DT FDA DT REPT COD AUTH NUM MFR NUM MFR SNDR LIT REF AGE AGE COD AGE GRP GNDR COD E SUB WT WT COD REPT DT TO MFR OCCP COD REPORTER COUNTRY OCCR COUNTRY
125115813 12511581 3 F 20160406 20160825 20160630 20160907 EXP GB-SUN PHARMACEUTICAL INDUSTRIES LTD-2016RR-119197 RANBAXY 67.00 YR F Y 80.00000 KG 20160907 OT GB GB

Drug(s) used by person

Event ID CASEID DRUG SEQ ROLE COD DRUGNAME PROD AI VAL VBM ROUTE DOSE VBM CUM DOSE CHR CUM DOSE UNIT DECHAL RECHAL LOT NUM EXP DT NDA NUM DOSE AMT DOSE UNIT DOSE FORM DOSE FREQ
125115813 12511581 1 PS CIPROFLOXACIN. CIPROFLOXACIN 1 Unknown UNK U U 75747
125115813 12511581 2 SS CLEXANE ENOXAPARIN SODIUM 1 Unknown 120 MG/ML, DAILY, 6 WEEK COURSE ENDED AFTER 32 DAYS 5SA23(12/16) 5SA74(01/17) 5SF52(03/17) 5SL64(08/ Y U 5SK16 0
125115813 12511581 3 C Adcal-D3 CALCIUM CARBONATECHOLECALCIFEROL 1 Unknown UNK U U 0
125115813 12511581 4 C LETROZOLE. LETROZOLE 1 Unknown UNK U U 0
125115813 12511581 5 C OMEPRAZOLE. OMEPRAZOLE 1 Unknown UNK U U 0
125115813 12511581 6 C Zomorph MORPHINE SULFATE 1 Unknown UNK U U 0
125115813 12511581 7 C PERJETA PERTUZUMAB 1 Unknown UNK U U 0
125115813 12511581 8 C HERCEPTIN TRASTUZUMAB 1 Unknown 1 DF, EVERY 3 WEEKS U U 0 1 DF
125115813 12511581 9 C Pertuzumab PERTUZUMAB 1 Unknown 1 DF, EVERY 3 WEEKS U U 0 1 DF
125115813 12511581 10 C Denosumab DENOSUMAB 1 Unknown 1 DF, EVERY 6 WEEKS U U 0 1 DF
125115813 12511581 11 C DOCETAXEL. DOCETAXEL 1 Unknown UNK U U 0
125115813 12511581 12 C Diuretic UNSPECIFIED INGREDIENT 1 Unknown UNK U U 0 TABLET

Indications of drugs used

Event ID CASEID INDI DRUG SEQ INDI PT
125115813 12511581 1 Antibiotic therapy
125115813 12511581 2 Peripheral embolism
125115813 12511581 3 Product used for unknown indication
125115813 12511581 4 Product used for unknown indication
125115813 12511581 5 Product used for unknown indication
125115813 12511581 6 Product used for unknown indication
125115813 12511581 7 Product used for unknown indication
125115813 12511581 8 Breast cancer stage IV
125115813 12511581 9 Breast cancer stage IV
125115813 12511581 10 Bone disorder
125115813 12511581 11 Breast cancer stage IV
125115813 12511581 12 Product used for unknown indication

Outcome of event

Event ID CASEID OUTC COD
125115813 12511581 LT
125115813 12511581 HO
125115813 12511581 OT

Reactions reported

Event ID CASEID DRUG REC ACT PT
125115813 12511581 Blister
125115813 12511581 Burning sensation
125115813 12511581 Dermatitis
125115813 12511581 Erythema multiforme
125115813 12511581 Pain
125115813 12511581 Protein deficiency
125115813 12511581 Rash erythematous
125115813 12511581 Scab
125115813 12511581 Skin erosion
125115813 12511581 Skin haemorrhage
125115813 12511581 Tachycardia

Reporting Sources (this data is often not reported and may therefore be missing here)

no results found

Therapies reported

Event ID CASEID DSG DRUG SEQ START DT END DT DUR DUR COD
125115813 12511581 2 20160317 20160417 0
125115813 12511581 3 20151016 0
125115813 12511581 11 20160210 0